TABLE 3.
Liver stiffness measurement (LSM values) before and during treatment
| Pat # | Cirrhosis | Pretreatment LSM (kPa) | BLV year 1 LSM (kPa) | Virological response at year 1 (∆log HDV‐RNA) |
|---|---|---|---|---|
| P 2 | Yes | 26.3 | 15.6 (−41%) | −1.16 |
| P 3 | No | 9.1 | 4.9 (−46%) | −2.80 |
| P 4 | Yes | 17.2 | 18.2 (+6%) | −3.00 |
| P 6 | Yes | 10.2 | 5.3 (−48%) | −0.47 |
| P 7 | Yes | 18.6 | 9.6 (−48%) | −0.52 |
| P 8 | No | 5.5 | 5.1 (−7%) | RNA undetectable |
| P 9 | Yes | 35.8 | 28.3 (−21%) | RNA undetectable |
| P 11 | Yes | 25.3 | 27.5 (+9%) | −2.08 a |
| P 13 | Yes | 10.2 | 8.9 (−13%) | −1.37 |
| P 19 | Yes | 48.0 | 26.8 (−44%) | −1.32 |
| P 22 | No | 6.8 | 5.5 (−19%) | −2.40 |
a
P11 had intermittent, significant alcohol abuse.
Green background: clinically relevant decrease in liver stiffness or HVPG; Yellow background: insignificant change in liver sitffness or HVPG; Red background: clinically increase in liver stiffness or HVPG.